{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:46:22Z","timestamp":1774633582656,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1186\/s43141-022-00376-7","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T06:02:59Z","timestamp":1657000979000},"page":"97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients"],"prefix":"10.1016","volume":"20","author":[{"given":"Nagaraj V.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reshma A.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchetha","family":"Kumari N","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijith V.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha A.","family":"Kalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3091-4976","authenticated-orcid":false,"given":"Prashanth","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1186\/s43141-022-00376-7_bib1","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De","year":"2016","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1186\/s43141-022-00376-7_bib2","first-page":"656","article-title":"Gene expression profiling of acute myeloid leukaemia samples from adult patients with AML-M1 and -M2 through boutique microarrays. Real-Time PCR and Droplet Digital PCR","volume":"52","author":"Handschuh","year":"2018","journal-title":"Int J Oncol"},{"issue":"9617","key":"10.1186\/s43141-022-00376-7_bib3","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1186\/s43141-022-00376-7_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4103\/0019-509X.55546","article-title":"Epidemiology of childhood cancer in India","volume":"46","author":"Arora","year":"2009","journal-title":"Indian J Cancer"},{"issue":"1","key":"10.1186\/s43141-022-00376-7_bib5","first-page":"73","article-title":"Prame gene expression in acute leukaemia and its clinical significance","volume":"9","author":"Ding","year":"2012","journal-title":"Cancer Biol Med"},{"issue":"5","key":"10.1186\/s43141-022-00376-7_bib6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1046\/j.1365-2141.1998.00982.x","article-title":"PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells","volume":"102","author":"Baren","year":"1998","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1186\/s43141-022-00376-7_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ajh.20425","article-title":"PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects","volume":"79","author":"Paydas","year":"2005","journal-title":"Am J Hematol"},{"issue":"16","key":"10.1186\/s43141-022-00376-7_bib8","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.ejca.2006.06.018","article-title":"Childhood acute myelogenous leukaemia: association between PRAME, apoptosis-and MDR-related gene expression","volume":"42","author":"Goellner","year":"2006","journal-title":"Eur J Cancer"},{"issue":"06","key":"10.1186\/s43141-022-00376-7_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9864.1000373","article-title":"Clinical importance of prame gene expression in acute myeloid leukemia","volume":"07","author":"Baraka","year":"2016","journal-title":"J Blood Disord Trans"},{"issue":"6","key":"10.1186\/s43141-022-00376-7_bib10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2005.07.003","article-title":"The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signalling","volume":"122","author":"Epping","year":"2005","journal-title":"Cell"},{"issue":"47","key":"10.1186\/s43141-022-00376-7_bib11","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1038\/sj.onc.1206936","article-title":"Retinoids in cancer therapy and chemoprevention: promise meets resistance","volume":"22","author":"Freemantle","year":"2003","journal-title":"Oncogene"},{"issue":"4","key":"10.1186\/s43141-022-00376-7_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"10.1186\/s43141-022-00376-7_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50341-7","article-title":"HLA class I-restricted T cell epitopes isolated and identified from myeloid leukemia cells","volume":"9","author":"Nyambura","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"10.1186\/s43141-022-00376-7_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.leukres.2006.02.031","article-title":"PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma","volume":"30","author":"Proto-Siqueira","year":"2006","journal-title":"Leukemia Res"},{"issue":"6","key":"10.1186\/s43141-022-00376-7_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/CJI.0000000000000322","article-title":"WT1, PRAME, and PR3 mRNA expression in acute myeloid leukemia (AML)","volume":"43","author":"Steger","year":"2020","journal-title":"J Immunother"},{"issue":"5","key":"10.1186\/s43141-022-00376-7_bib16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.leukres.2006.06.006","article-title":"Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia","volume":"31","author":"Spanaki","year":"2007","journal-title":"Leukemia Res"},{"issue":"1","key":"10.1186\/s43141-022-00376-7_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-4608(02)00582-4","article-title":"PRAME gene expression in childhood acute lymphoblastic leukemia","volume":"138","author":"Steinbach","year":"2002","journal-title":"Cancer Gen Cytogenet"},{"issue":"2","key":"10.1186\/s43141-022-00376-7_bib18","first-page":"1","article-title":"PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis","volume":"1","author":"Ca","year":"2014","journal-title":"Clin Lab"},{"issue":"15","key":"10.1186\/s43141-022-00376-7_bib19","first-page":"3299","article-title":"The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells","volume":"114","author":"Oehler","year":"2009","journal-title":"Blood J Am Soc Hematol"},{"issue":"8","key":"10.1186\/s43141-022-00376-7_bib20","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proceed Natl Acad Sci"},{"issue":"3","key":"10.1186\/s43141-022-00376-7_bib21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.leukres.2008.08.026","article-title":"Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease","volume":"33","author":"Qin","year":"2009","journal-title":"Leukemia Res"},{"issue":"13","key":"10.1186\/s43141-022-00376-7_bib22","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1182\/blood-2006-01-023127","article-title":"Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches","volume":"108","author":"Greiner","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1186\/s43141-022-00376-7_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3889\/oamjms.2015.001","article-title":"Preferentially expressed antigen of melanoma (PRAME) and wilms\u2019 tumor 1 (WT 1) genes expression in childhood acute lymphoblastic leukemia, prognostic role and correlation with survival","volume":"3","author":"El Khateeb","year":"2015","journal-title":"Macedonian J Med Sci"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-022-00376-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43141-022-00376-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23008582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23008582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-022-00376-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:58:10Z","timestamp":1761659890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X23008582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1687157X23008582"],"URL":"https:\/\/doi.org\/10.1186\/s43141-022-00376-7","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s43141-022-00376-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Academy of Scientific Research and Technology. Published by Elsevier BV.","name":"copyright","label":"Copyright"}],"article-number":"97"}}